Insufficient scRNA-seq data for expression of IFNA21 at single-cell level.
Insufficient scRNA-seq data for expression of IFNA21 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 78% | 8.19 | 2059 / 2642 | 0% | 0.00 | 1 / 705 |
adrenal gland | 43% | 1.38 | 110 / 258 | 1% | 0.02 | 3 / 230 |
spleen | 42% | 1.44 | 102 / 241 | 0% | 0 | 0 / 0 |
intestine | 42% | 1.47 | 405 / 966 | 0% | 0 | 0 / 527 |
lung | 39% | 1.20 | 226 / 578 | 0% | 0.00 | 2 / 1155 |
thymus | 36% | 1.18 | 236 / 653 | 0% | 0 | 0 / 605 |
esophagus | 30% | 0.90 | 432 / 1445 | 2% | 0.02 | 3 / 183 |
blood vessel | 28% | 0.81 | 376 / 1335 | 0% | 0 | 0 / 0 |
kidney | 28% | 0.85 | 25 / 89 | 0% | 0 | 0 / 901 |
uterus | 25% | 0.66 | 42 / 170 | 0% | 0 | 0 / 459 |
stomach | 24% | 0.67 | 86 / 359 | 1% | 0.01 | 2 / 286 |
breast | 22% | 0.63 | 102 / 459 | 0% | 0.01 | 3 / 1118 |
prostate | 21% | 0.67 | 51 / 245 | 0% | 0.00 | 1 / 502 |
heart | 20% | 0.49 | 169 / 861 | 0% | 0 | 0 / 0 |
bladder | 19% | 0.38 | 4 / 21 | 0% | 0 | 0 / 504 |
ovary | 19% | 0.46 | 34 / 180 | 0% | 0 | 0 / 430 |
adipose | 18% | 0.48 | 216 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.68 | 5 / 29 |
peripheral blood | 13% | 0.30 | 120 / 929 | 0% | 0 | 0 / 0 |
skin | 12% | 0.32 | 220 / 1809 | 0% | 0 | 0 / 472 |
pancreas | 11% | 0.30 | 36 / 328 | 0% | 0 | 0 / 178 |
muscle | 10% | 0.29 | 84 / 803 | 0% | 0 | 0 / 0 |
liver | 6% | 0.15 | 14 / 226 | 0% | 0 | 0 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0002250 | Biological process | adaptive immune response |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0098586 | Biological process | cellular response to virus |
GO_0042100 | Biological process | B cell proliferation |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0051607 | Biological process | defense response to virus |
GO_0033141 | Biological process | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO_0002323 | Biological process | natural killer cell activation involved in immune response |
GO_0030183 | Biological process | B cell differentiation |
GO_0002286 | Biological process | T cell activation involved in immune response |
GO_0006959 | Biological process | humoral immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005126 | Molecular function | cytokine receptor binding |
GO_0005132 | Molecular function | type I interferon receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IFNA21 |
Protein name | Interferon alpha-21 (IFN-alpha-21) (Interferon alpha-F) (LeIF F) |
Synonyms | |
Description | FUNCTION: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. . |
Accessions | P01568 ENST00000380225.1 |